February 19, 2009
West Penn Allegheny Health System (WPAHS)
officials announced today that Michael DeVita M.D., has been appointed to the newly created position of
Executive Vice President, Medical Affairs. He will
assume the post in April.
Dr. DeVita presently
serves as the Associate Medical Director for Quality and Medical Management for
the University of Pittsburgh Medical Center (UPMC) system. Prior
to that he was Vice President of the Medical Staff for Surgical-Based Services
at
“With the hiring of Dr. DeVita
we have taken yet another step in reaching our goal of establishing a truly
physician-driven organization and being uniquely positioned in our marketplace
to address the challenges and opportunities facing our industry, said
Christopher T. Olivia, M.D., WPAHS president and chief executive officer.
“As both a clinician and healthcare executive
Dr. DeVita brings significant experience and
accomplishments to the position.”
In his new duties Dr. DeVita
will be responsible for West Penn Allegheny Health System’s nationally lauded
initiatives in quality, medical education and research.
“Given his unyielding commitment to excellence
and his far-reaching stellar reputation, we are certain that Dr. DeVita will lead these areas to even greater heights,” Dr.
Olivia said.
Dr. DeVita earned both his undergraduate and medical
degrees from
Dr. DeVita is
board-certified in Internal and Critical Medicine. He is a Fellow in the
A highly regarded medical ethicist and expert
in end-of-life decisions, Dr. DeVita has over
100 publications dealing with critical care, patient safety and ethics in such
journals as the Archives of Internal Medicine, The Kennedy Institute of Ethics,
Quality and Safety in Healthcare, and Critical Care Medicine. He has been an
Associate Editor of the journal Simulation in Healthcare, and is a Column
Editor for the Joint Commission’s Journal on Quality and Patient Safety. He is
lead author of the first textbook on rapid response systems, entitled Medical
Emergency Teams.
Dr. DeVita is also
active in the community, most notably as a member of the Clinical Affairs
Advisory Committee for the Juvenile Diabetes Research Foundation and the
International Juvenile Diabetes Research Foundation Stem Cell Research Advisory
Committee.